EarlySight will be attending the Association for Research in Vision and Ophthalmology (ARVO) congress 2024 (booth #1332) which will take place in the Seattle Convention Center – Arch Building from 5 – 9 May 2024 in Seattle, Wash (USA).
The ARVO 2024 Congress is a must-attend event connecting worldwide approximately 10 000 scientists, ophthalmologists and innovators interested in retina science, eye and vision research from around the world.
The following abstracts will be presented by our clinical research teams partners about their studies on cellular level images of the retina acquired using Cellularis Discovery on CSCR, AMD and inherited macular dystrophies, or using selective retina therapy (SRT).
𝐏𝐨𝐬𝐭𝐞𝐫 𝟒𝟖𝟔𝟗𝟖𝟓: ARVO Imaging in the Eye Conference 2024, Christian Burri, PhD, Bern University of Applied Sciences (BFH), Switzerland, In vivo assessment of human retinal pigment epithelium after selective retina therapy using transscleral flood illumination in combination with adaptive optics.
𝐏𝐨𝐬𝐭𝐞𝐫 𝐀𝟎𝟑𝟐𝟒: ARVO 2024,Prof Andrea Cusumano, MD, PhD, Universita degli Studi di Roma Tor Vergata Facolta di Medicina e Chirurgia, Italy, Cellular analysis of retinal pigment epithelium and photoreceptors by transscleral optical imaging in inherited macular dystrophies.
𝐏𝐨𝐬𝐭𝐞𝐫 𝐀𝟎𝟑𝟐𝟑: ARVO 2024, Mihaela Chitoroaga, MD, Swiss Visio Montchoisi, Switzerland, Adaptive Optics-enhanced dual retinal layer imaging and region reflectivity-based segmentation: unveiling variances in healthy and diseased retina.
𝐏𝐨𝐬𝐭𝐞𝐫 𝐀𝟎𝟑𝟎𝟕: ARVO 2024, Laura Kowalczuk, PhD, Hopital ophtalmique Jules-Gonin, Switzerland, Analysis of Retinal Pigment Epithelium in Central Serous Chorioretinopathy using Adaptive Optics-Transscleral Flood Illumination.
Get in touch at our booth #1332 with our team Timothé Laforest and Benedetto Sgroi if you want to set up a meeting while at the conference.
